Expert Video - How does AML classification help predict treatment outcomes?
Dr. Jamile Shammo, an expert on acute myeloid leukemia (AML), explains how AML classification helps predict treatment outcomes. Based on the genetics of your AML, doctors will classify your AML as favorable, intermediate, or adverse risk group (good, medium, or poor). Along with your age and other factors (such as your general health), your risk group helps determine your treatment plan.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.
Other Modules:
Animation - Treatment Failure and Relapse
Slide Show - Treatment Failure and Relapse
1.
What is treatment failure and relapse in AML?
2.
Who is at risk of treatment failure and relapse in AML?
3.
What happens in treatment failure in AML?
4.
Why does AML treatment failure happen after chemo and/or radiation therapy?
5.
How common is treatment failure and relapse in AML?
6.
Can AML be cured?
7.
How does targeted therapy impact AML remission?
8.
Is remission the same in younger or older patients with AML?
9.
How does AML classification help predict treatment outcomes?
10.
Are clinical trials an option in treatment failure or relapse in AML?
11.
Ed's story: What has your AML diagnosis and treatment journey been so far?
12.
Ed's story: What has helped you cope on a daily basis with your AML diagnosis?
13.
Ed's story: What advice do you have for other patients on their journey with AML?
14.
Paul's story: How was your AML diagnosed and what experiences have you had with treatment?
15.
Paul's story: What advice do you have for other patients with AML?
16.
Peggy's story: How did you find out you had AML?
17.
Peggy's story: How did you first cope with your diagnosis of AML?
18.
Peggy's story: What advice do you have for other AML patients managing treatment side effects?
